Literature DB >> 10487403

Prevalence of atypical chest pain descriptions in a population from the southern United States.

R L Summers1, G J Cooper, F B Carlton, M E Andrews, J C Kolb.   

Abstract

INTRODUCTION: The character of chest pain (CP) is a major factor determining triage and admission for patients presenting to the emergency department (ED). Previous studies have found atypical descriptions in as little as 10-15% of patients with true myocardial ischemic pain. Atypical descriptions may be more prevalent in the Deep South of the United States because of cultural differences in the semantic description of pain.
METHODS: A retrospective study of patients presenting to the ED of a southern U.S. urban hospital with enzyme-documented myocardial infarction was conducted to determine the prevalence of atypical CP descriptions. A multivariate analysis of those patients with atypical pain descriptions was conducted to determine the independent demographic factors associated with these descriptions.
RESULTS: In a total of 77 subjects (56% black; 44% white) meeting the study criteria, 43% were found to have atypical elements in the character of their CP descriptions. Only the black race demographic was found to be significantly correlated with the atypical descriptions. The use of the descriptive term "sharp" accounted for nearly half of the atypical presentations.
CONCLUSION: Regional differences in the description of the character of CP may result in misleading portrayals of ischemic heart disease in southern U.S. populations. These differences are associated with a higher prevalence of atypical CP because of semantic distinctions, such as the use of the term "sharp" as a descriptor of acuity rather than character or quality.

Entities:  

Mesh:

Year:  1999        PMID: 10487403     DOI: 10.1097/00000441-199909000-00008

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  8 in total

Review 1.  Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 1).

Authors:  Shehzad Sami; James T Willerson
Journal:  Tex Heart Inst J       Date:  2010

2.  Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.

Authors:  Jo-Ann Eastwood; B Delia Johnson; Thomas Rutledge; Vera Bittner; Kerry S Whittaker; David S Krantz; Carol E Cornell; Wafia Eteiba; Eileen Handberg; Diane Vido; C Noel Bairey Merz
Journal:  J Womens Health (Larchmt)       Date:  2013-08-30       Impact factor: 2.681

3.  Racial differences in reperfusion therapy use in patients hospitalized with myocardial infarction: a regional phenomenon.

Authors:  Saif S Rathore; Paul D Frederick; Nathan R Every; Hal V Barron; Harlan M Krumholz
Journal:  Am Heart J       Date:  2005-06       Impact factor: 4.749

4.  Regional variations in racial differences in the treatment of elderly patients hospitalized with acute myocardial infarction.

Authors:  Saif S Rathore; Frederick A Masoudi; Edward P Havranek; Harlan M Krumholz
Journal:  Am J Med       Date:  2004-12-01       Impact factor: 4.965

Review 5.  Acute coronary syndromes in black Americans: is treatment different? Should it be?

Authors:  Luther T Clark; Umesh Lingegowda
Journal:  Curr Cardiol Rep       Date:  2005-07       Impact factor: 2.931

6.  Bangladeshi patients present with non-classic features of acute myocardial infarction and are treated less aggressively in east London, UK.

Authors:  K Barakat; Z Wells; S Ramdhany; P G Mills; A D Timmis
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

7.  Radiation-induced heart disease: a clinical update.

Authors:  Syed Wamique Yusuf; Shehzad Sami; Iyad N Daher
Journal:  Cardiol Res Pract       Date:  2011-02-27       Impact factor: 1.866

8.  Emergency department routine data and the diagnosis of acute ischemic heart disease in patients with atypical chest pain.

Authors:  Ki Hong Kim; Jeong Ho Park; Young Sun Ro; Ki Jeong Hong; Kyoung Jun Song; Sang Do Shin
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.